Dave Muoio

June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...
June 20, 2018
The US’s struggle with opioid addiction rages on, and Facebook seems to have heard critics’ warnings about social media’s role in the epidemic. During an event yesterday, representatives from the company announced that users trying to purchase opioids or find addiction treatment through their platform will be redirected to information about a federal crisis helpline, according to reports from...
Walmart patent for blockchain, wearable, biometric scanner-based EHR system
June 19, 2018
Walmart’s ongoing investigation of blockchain technologies seems to have intersected with its growing interest in joining the healthcare space, according to a patent application released earlier this week by the US Patent and Trademark Office. According to the document, which was filed in December, the retail giant is seeking to protect a method that allows a patient’s EHR to be obtained from a...
Clinics on Wheels units will go to Puerto Rico

A new partnership will deploy three custom-built solar-powered mobile medical clinics to Puerto Rico. Credit:

June 19, 2018
AI-based patient safety company MedAware has announced a partnership with Allscripts that will bring its medication decision support product to the latter company’s EHR system. With this, providers choosing a prescription for their patients in a live setting will receive notifications concerning medication-related risks, such as adverse drug events or opioid dependency, and can amend their...
June 18, 2018
To all of the people who work with machine learning and neural networks healthcare technologies, but can’t describe exactly how the gears are turning — don’t worry, you’re not alone. In a sold-out discussion hosted at Optum’s Boston office and organized by the Design Museum Foundation, Sanji Fernando, vice president and head of OptumLabs’ Center for Applied Data Science, explained how the ongoing...
June 18, 2018
Pasadena, California-based Embodied announced today it has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness. The investment is led by Calibrate Ventures and Jazz Venture Partners, and had participation from previous backers including Osage University Partners, Intel Capital, Grishin Robotics, and others. “We are developing a software...
DreaMed Diabetes tool gets FDA approval
June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...
June 14, 2018
Biometric sensor technology company Valencell announced this week that it has raised $10.5 million in Series E, bringing the company’s total funding to $35 million. The new backing primarily comes as the result of a strategic investment by hearing instrument and specialty earphone company Sonion a/s, with additional participation from prior investors including TDF Ventures, GII LLC, and WSJ...

Credit:

June 14, 2018
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal. The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European branch. "This device offers hope to...
June 14, 2018
The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). The studies, published in npj Digital Medicine, the Journal of Affective Disorders, and presented at the Society of Biological Psychiatry Annual Scientific Convention in New York, showed the therapeutic to reduce symptoms, pair well with...